Search Results
Aug 05, 2026, 08:30 ET NNN REIT, Inc. Announces Second Quarter 2026 Results
produces an annualized amount as of a point in time but does not take into consideration future (i) scheduled rent increases, (ii) leasing activity, or (iii) lease expirations.Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate ("EBITDAre") as defined by the National
More news about: NNN REIT, Inc.
Aug 05, 2026, 08:00 ET Southwest Gas Holdings, Inc. Reports Second Quarter 2026 Financial Results, Reaffirms Full-Year 2026 Guidance
Holdings adjusted earnings (loss) per share from continuing operations, (ii) Southwest Gas Holdings adjusted net income (loss) from continuing operations, (iii) Natural Gas Distribution segment adjusted earnings (loss) per share, and (iv) Natural Gas Distribution segment adjusted net income (loss) for the three
More news about: Southwest Gas Holdings, Inc.
Aug 05, 2026, 07:30 ET TAE Technologies and Black Moon Energy Corporation Enter into Strategic Helium-3 Supply and Commercialization Agreement for Fusion Power
related thereto; (ii) the outcome of any legal proceedings that may be instituted against TMTG or TAE with respect to site selection or the TMTG Merger; (iii) the inability to complete the TMTG Merger due to the failure to obtain approval of the shareholders of TMTG or TAE, or other conditions to closing in
More news about: TAE Technologies, Inc.
Aug 05, 2026, 07:27 ET Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference
department visits, and hospitalizations. The program comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing pivotal Phase III MAVERIC trial (NCT06708299). The U.S. FDA has granted Orphan Drug Designation to CardiolRx™ for the treatment of pericarditis, including recurrent
More news about: Cardiol Therapeutics Inc.
Aug 05, 2026, 07:00 ET Galaxy Announces Second Quarter 2026 Financial Results
CoreWeave Leases (Phases I+II+III)
More news about: Galaxy Digital Inc.
Aug 05, 2026, 06:59 ET Hydrogen Storage Tanks and Transportation Market worth $2,280.6 million by 2031 | MarketsandMarkets™
trends. The rapid deployment of hydrogen-powered buses, trucks, passenger vehicles, railways, and marine vessels is driving demand for advanced Type III and Type IV composite storage tanks. Simultaneously, large-scale investments in green hydrogen production, hydrogen refueling stations, hydrogen hubs,
More news about: MarketsandMarkets
Aug 05, 2026, 06:55 ET Hagerty Reports Second Quarter 2026 Results
Drivers Club ("HDC") subscribers; (ii) maintain key strategic relationships with Hagerty's insurance distribution and underwriting carrier partners; (iii) prevent, monitor, and detect fraudulent activity; (iv) manage risks associated with disruptions, interruptions, outages, or other issues with Hagerty's
More news about: Hagerty
Aug 05, 2026, 06:49 ET CMC Highlights Position as a Leading, Early-Stage Construction Solutions Provider and Unveils Long-Term Financial Targets at 2026 Investor Day
allow: (i) comparison of our earnings to those of our competitors; (ii) a supplemental measure of our underlying business operational performance; and (iii) the assessment of period-to-period performance trends. 2 Defined as net earnings plus interest expense, income tax expense, depreciation
More news about: CMC
Aug 05, 2026, 06:30 ET Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
TABLE IIIPERRIGO COMPANY PLC
More news about: Perrigo Company plc
Aug 05, 2026, 06:27 ET Elanco Animal Health Reports Second Quarter 2026 Results
divestiture or amortization of intangible assets, that some may consider important in evaluating our performance, value or prospects for the future, (iii) they exclude items or types of items that may continue to occur from period to period in the future and (iv) they may not exclude all unusual or non-recurring
More news about: Elanco Animal Health
Aug 05, 2026, 02:52 ET Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Second Quarter of 2026
is comprised of net interest expense, exchange gain or loss, monetary position gain or loss and other financing costs and derivative transactions), (iii) other income, net, (iv) income tax, (v) (income) loss from discontinued operations.In managing the Company's business, Chunghwa Telecom relies
More news about: Chunghwa Telecom Co., Ltd.
Aug 04, 2026, 22:42 ET EQPT Investors Have Opportunity to Lead EquipmentShare.com Inc Securities Lawsuit
(ii) EquipmentShare had not terminated or substantially reduced a number of the transactions with entities owned or controlled by the co-founders; (iii) as a result, EquipmentShare's financial statements were materially misleading; and (iv) as a result of the foregoing, defendants' positive statements
More news about: THE ROSEN LAW FIRM, P. A.
Aug 04, 2026, 20:00 ET BABA INVESTOR ALERT: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead the Alibaba Class Action Lawsuit
military company; (ii) Alibaba was directly or indirectly controlled by or affiliated with the Chinese Ministry of Industry and Information Technology; (iii) the risk of Alibaba carrying out distillation attacks against third-party AI models was not a mere hypothetical or inadvertent, but ongoing; and (iv)
More news about: Robbins Geller Rudman & Dowd LLP
Aug 04, 2026, 18:30 ET Shutterstock Reports Second Quarter 2026 Financial Results
performance and overall liquidity; (ii) facilitate management's internal comparisons of the historical operating performance of its business operations; (iii) facilitate management's external comparisons of the results of its overall business to the historical operating performance of other companies that
More news about: Shutterstock, Inc.
Aug 04, 2026, 17:06 ET CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
a randomized, placebo-controlled Phase 2 study evaluating ifetroban as a potential therapy to inhibit cancer metastasis in patients with Stage I to III malignant solid tumors at high risk of metastatic recurrence. The study met its primary objective of assessing safety and feasibility. Ifetroban was
More news about: Cumberland Pharmaceuticals Inc.
Aug 04, 2026, 16:30 ET The Chemours Company Reports Second Quarter Results
Adjusted EBITDA, which adjust for (i) certain non-cash items, (ii) certain items we believe are not indicative of ongoing operating performance or (iii) certain nonrecurring, unusual or infrequent items to evaluate the Company's performance in order to have comparable financial results to analyze changes
More news about: The Chemours Company
Aug 04, 2026, 16:15 ET Talos Energy Announces Second Quarter 2026 Operational and Financial Results
supplemental indicators of the operational performance of our business, (ii) additional criteria for evaluating our performance relative to our peers and (iii) supplemental information to investors about certain material non-cash and/or other items that may not continue at the same level in the future. Adjusted
More news about: Talos Energy
Aug 04, 2026, 16:15 ET EOG Resources Reports Second Quarter 2026 Results
general, EOG excludes impairments which are (i) attributable to declines in commodity prices, (ii) related to sales of certain oil and gas properties or (iii) the result of certain other events or decisions (e.g., a periodic review of EOG's oil and gas properties or other assets). EOG believes excluding these
More news about: EOG Resources, Inc.
Aug 04, 2026, 16:15 ET ONE Gas Announces Second Quarter 2026 Financial Results; Raises 2026 Adjusted Earnings Expectations to Upper Half of Financial Guidance Ranges
prior to or when they become due and to fund our operations and capital expenditures, either through (i) cash on hand, (ii) operating cash flow, or (iii) access to the capital markets and other sources of liquidity;our ability to obtain capital on commercially reasonable terms, or
More news about: ONE Gas, Inc.
Aug 04, 2026, 16:10 ET ePlus Reports First Quarter Fiscal Year 2027 Financial Results
reconciliations below for the following non-GAAP financial measures: (i) Adjusted EBITDA, (ii) Non-GAAP: Net earnings from continuing operations and (iii) Non-GAAP Net earnings from continuing operations per common share - diluted.We define Adjusted EBITDA as net earnings from continuing operations
More news about: EPLUS INC.
Aug 04, 2026, 16:01 ET ALLEGIANT TRAVEL COMPANYSECOND QUARTER 2026 FINANCIAL RESULTS*
incurred primarily as the result of hurricanes and other insured events at Sunseeker Resort, (ii) other charges related to the sale of Sunseeker, and (iii) the airline special charges listed in the table below. We also present adjusted consolidated interest expense, adjusted consolidated income before income
More news about: Allegiant Travel Company
Aug 04, 2026, 16:01 ET Wynn Resorts, Limited Reports Second Quarter 2026 Results
Wynn Resorts, Limited to adjusted net income attributable to Wynn Resorts, Limited, (ii) operating income (loss) to Adjusted Property EBITDAR, and (iii) net income attributable to Wynn Resorts, Limited to Adjusted Property EBITDAR.
More news about: Wynn Resorts, Limited
Aug 04, 2026, 15:10 ET NNS adquiere acciones en OCI
riesgos relacionados con la obtención de aprobaciones regulatorias sin demoras o condiciones imprevistas y la posibilidad de acciones regulatorias; (iii) riesgos relacionados con costes significativos relacionados con la transacción; (iv) el rendimiento financiero y operativo esperado y las oportunidades
More news about: NNS Holding (Cyprus) Limited
Aug 04, 2026, 15:06 ET NNS erwirbt Anteile an OCI
im Zusammenhang mit dem Erhalt behördlicher Genehmigungen ohne unerwartete Verzögerungen oder Auflagen sowie die Möglichkeit behördlicher Maßnahmen; (iii) Risiken im Zusammenhang mit erheblichen Kosten der Transaktion; (iv) die erwartete finanzielle und operative Entwicklung sowie zukünftige Chancen nach
More news about: NNS Holding (Cyprus) Limited
Aug 04, 2026, 14:55 ET NNS fait l'acquisition d'actions d'OCI
risques liés à l'obtention des autorisations réglementaires sans retards ni conditions imprévus, ainsi que la possibilité de mesures réglementaires ; (iii) les risques liés aux coûts importants associés à l'opération ; (iv) les performances financières et opérationnelles attendues ainsi que les opportunités
More news about: NNS Holding (Cyprus) Limited